Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

29.96 +0.97 (+3.35%)
Streaming Delayed Price Updated: 3:29 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alkermes plc - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Lots Of Deal News ↗
Today Didi, a Chinese ride-hailing stock is doing its IPO reportedly at above the level projected in its application. 
Via Talk Markets
Topics Initial Public Offering
News headline image
Saint Warren ↗
Today the WTI oil price rose further up over 1%. 
Via Talk Markets
News headline image
Alkermes Announces Former Professional Baseball Player, CC Sabathia, as Spokesperson for Alcohol Dependence Awareness Campaign
SOURCE: Alkermes 
Via 3BL Media
News headline image
Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs ↗
Biogen isn't the only company whose shares should benefit from a breakthrough drug. 
Via The Motley Fool
News headline image
Alkermes Celebrates Alcoholics Anonymous Founders Day
SOURCE: Alkermes 
Via 3BL Media
The Boston Club Recognizes Alkermes plc and Blue Cross Blue Shield of Massachusetts With First President's Award
SOURCE: Alkermes 
Via 3BL Media
News headline image
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... 
Via Benzinga
News headline image
Wednesday News And Catch-Up ↗
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA. 
Via Talk Markets
Topics Stocks
News headline image
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Juvenile Investing Mob ↗
Tech stocks did well in Europe but not in the US. The data are unconvincing. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Alkermes: Diversity Strengthens Our Culture
SOURCE: Alkermes 
Via 3BL Media
News headline image
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
News headline image
A Better Switch ↗
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase. 
Via Talk Markets
News headline image
"I'm Incredibly Proud to Work at a Company Whose Mission Is To Help Families Like Mine"
SOURCE: Alkermes 
Via 3BL Media
News headline image
Alkermes Shares Move Higher On FDA Approval Of Schizophrenia, Bipolar Med ↗
The FDA has approved Alkermes plc's (NASDAQ: ALKS) Lybalvi, a once-daily, oral atypical antipsychotic composed of olanzapine, an established antipsychotic... 
Via Benzinga
News headline image
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
News headline image
Alkermes Inspiration Grants® 2021 Applications Are Now Open
SOURCE: Alkermes 
Via 3BL Media
News headline image
Alkermes Celebrates Mental Health Month
SOURCE: Alkermes 
Via 3BL Media
Alkermes Announces 2021 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer
SOURCE: Alkermes 
Via 3BL Media
News headline image
Why Shares of Alkermes Rose 18% Last Month ↗
An agreement with an activist investor capped a busy month. 
Via The Motley Fool
News headline image
Want to Make Money in Biotech? Do This First ↗
Keeping track of upcoming events is important. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
SOURCE: Alkermes 
Via 3BL Media
Topics Regulatory Compliance
News headline image
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Alkermes PLC (ALKS) Q1 2021 Earnings Call Transcript ↗
ALKS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Alkermes Launches New Disease State Website to Offer Education About Alcohol Dependence
SOURCE: Alkermes 
Via 3BL Media
News headline image
Alkermes: Q1 Earnings Insights ↗
Shares of Alkermes (NASDAQ:ALKS) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share increased 1000.00% year over year to $0.11,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.